Report Details

Global Bioabsorbable Vascular Scaffolds Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2019 to 2025

ID : 7745283
Date : May 2019
Pages : 213 Pages
Industry : Pharmaceutical and Healthcare


Bioabsorbable vascular scaffolds are naturally dissolving scaffolds used in the treatment of coronary artery disease CAD. These are the latest development in stent technology made up of metal and coated with a polymer containing anti-proliferative drugs such as Sirolimus or Everolimus. These Bioabsorbable vascular scaffolds disintegrated in the human body. Hence, these stents remove the post-treatment operations and prevents the inflammation leading to thrombosis and stent restenosis. Bioabsorbable vascular scaffolds are inserted by percutaneous transluminal coronary angioplasty and commonly preferred over the permanent implants owing to need anticoagulation treatment for a long time and reduce host/device interaction.



Global bioabsorbable vascular scaffolds market is expanding at robust CAGR due to increasing geriatric population. The major driving factors are rise in incidences of cardiac disorders such as peripheral and coronary artery diseases and increase in the prevalence of obesity. Moreover, various pipeline products, technological advancements for new products, rise in demand for biocompatible and safe coronary stents, and degradation time for the stents might boost the growth of bioabsorbable vascular scaffolds market in the forecast period. However, stringent regulatory guidelines, slow adoption of stents in the disease management, lack of reimbursement policies, and the alternative treatment for the coronary artery diseases will hinder the growth of global bioabsorbable vascular scaffolds market in the forecast period.



The bioabsorbable vascular scaffolds market is segmented based on the material type, product type, area of application, and end-user



Based on the product type, bioabsorbable vascular scaffolds market has been segmented into the following:

Synthetic
Biological
Biosynthetic


Based on the material type, bioabsorbable vascular scaffolds market has been segmented into the following:

Metal based BVS
Polymer based BVS


Based on the application, bioabsorbable vascular scaffolds market has been segmented into the following:

Coronary artery stents
Peripheral artery stents


Based on the end-user, bioabsorbable vascular scaffolds market has been segmented into the following:

Hospitals
Cardiac centres
Ambulatory surgical centers


The global bioabsorbable vascular scaffolds market is in the nascent stage, rise in R&D is expected to offer novel products to global bioabsorbable vascular scaffolds market. Various competitors are actively involved in the development of bioabsorbable vascular scaffolds for increasing their market revenue. For instance, under ‘Medtronic CardioVascular Bioabsorbable’ program Medtronic Inc. is focusing to develop completely bioabsorbable scaffolds for superficial femoral arteries.  The global bioabsorbable vascular scaffolds market is anticipated to grow at a tremendous rate due to increase in technological innovations in the forecasting period. Launching of new products, approvals from various regulatory bodies, collaborations are might boosting the growth of global bioabsorbable vascular scaffolds market. For instance, in August 2015, Abbott Vascular received CE mark approval for bioabsorbable vascular scaffold with catheter delivery system. Similarly, in January 2013, FDA granted approval for Xience Xpedition manufactured by Abbott Vascular, Inc. and the company launched the product in U.S.  Further studies for the development of bioabsorbable coronary scaffold would bring a couple of new products to the market improve the growth of global bioabsorbable vascular scaffolds market over the forecast period. Even though technological and clinical development of bioabsorbable vascular stents is not yet complete and possible clinical benefits over metallic stents are still unrevealed, there are no solid reasons that can limit the clinical use of bioabsorbable vascular scaffolds.

 



Geographically, global bioabsorbable vascular scaffolds market has been segmented into following regions Viz. Europe, North America, Asia-Pacific, Latin America, and Middle East & Africa. North America region is expected to hold the largest share in the global bioabsorbable vascular scaffolds market owing to technological advancements, increased awareness regarding the treatment of coronary disorders in bioabsorbable vascular stents, and products available in the pipeline help in the growth of global bioabsorbable vascular scaffolds market. Europe region is expected to hold a significant growth attributed to increase in geriatric population, change in lifestyle, increase in healthcare infrastructure, and technological advancements in Europe countries such as Germany, UK, and France might fuel the growth of global bioabsorbable vascular scaffolds market. However, Asia-Pacific  witness a significant growth rate in bioabsorbable vascular scaffolds market owing to Increase in awareness about peripheral and coronary artery diseases, rise in the prevalence of artery diseases in Asia Pacific region, favourable government policies, and low cost for the stents in Asia Pacific countries such as India bolster the market over the forecast timeframe. Furthermore, diversification of business segment by the competitors in Asia Pacific region due to increase in medical tourism also fuel the bioabsorbable vascular scaffolds. Latin America and the Middle East and Africa has a lucrative growth in Bioabsorbable vascular scaffolds market attributed to increase in initiatives by the private and public sectors and entry of new products into the market.



Some of the players in global bioabsorbable vascular scaffolds market are Medtronic U.S., Abbott Laboratories U.S, Boston Scientific Corporation U.S., Biosensors International Group, Ltd. Singapore, Biotronik SE & Co. KG Germany, C.R. Bard Inc. U.S., Stentys SA France, Svelte Medical Systems, Inc. U.S., and REVA Medical, Inc. U.S., to name a few



In April 2018, REVA Medical’s Fantom sirolimus-eluting bioresorbable scaffold received CE mark


In July 2016, FDA has approved the Absorb GT Bioresorbable Vascular Scaffold BVS System manufactured by Abbott Vascular, Inc


In January 2016, Svelte Medical announced the European launch of low profile drug-eluting stent resulting in smaller delivery catheter and easier implantation




Report Outline:



The report provides granular level information about the market size, regional market share and forecast from 2019-2025
The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
The report tracks recent innovations, key developments and startup’s details that are working in the industry
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
1. Executive summary
2. Global Bioabsorbable Vascular Scaffolds Market Introduction
2.1. Global Bioabsorbable Vascular Scaffolds Market– Taxonomy
2.2. Global Bioabsorbable Vascular Scaffolds Market–Definitions
2.2.1. End User
2.2.2. Product Type
3. Global Bioabsorbable Vascular Scaffolds Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Bioabsorbable Vascular Scaffolds Market Dynamics – Factors Impact Analysis
3.6. Global Bioabsorbable Vascular Scaffolds Market– Recent Market Introductions
4. Global Bioabsorbable Vascular Scaffolds Market Analysis, 2014 - 2018 and Forecast, 2019 – 2025
4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
4.2. Year-over-Year Y-o-Y Growth Analysis %
4.3. Market Oppurtunity Analysis
5. Global Bioabsorbable Vascular Scaffolds Market Forecast, By Product Type, 2014 - 2018 and Forecast, 2019 - 2025
5.1. Synthetic
5.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
5.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
5.1.3. Market Opportunity Analysis
5.2. Biological
5.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
5.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
5.2.3. Market Opportunity Analysis
5.3. Biosynthetic
5.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
5.3.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
5.3.3. Market Opportunity Analysis
6. Global Bioabsorbable Vascular Scaffolds Market Forecast, By Material Type, 2014 - 2018 and Forecast, 2019 - 2025
6.1. Metal based BVS
6.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
6.1.3. Market Opportunity Analysis
6.2. Polymer based BVS
6.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
6.2.3. Market Opportunity Analysis
7. Global Bioabsorbable Vascular Scaffolds Market Forecast, By Application, 2014 - 2018 and Forecast, 2019 - 2025
7.1. Coronary Artery Stents
7.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
7.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
7.1.3. Market Opportunity Analysis
7.2. Peripheral Artery Stents
7.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
7.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
7.2.3. Market Opportunity Analysis
8. Global Bioabsorbable Vascular Scaffolds Market Forecast, By End User, 2014 - 2018 and Forecast, 2019 - 2025
8.1. Hospitals
8.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
8.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
8.1.3. Market Opportunity Analysis
8.2. Cardiac Centres
8.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
8.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
8.2.3. Market Opportunity Analysis
8.3. Ambulatory Surgical Centers
8.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
8.3.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
8.3.3. Market Opportunity Analysis
9. Global Bioabsorbable Vascular Scaffolds Market Forecast, By Region, 2014 - 2018 and Forecast, 2019 - 2025
9.1. North America
9.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
9.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
9.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
9.3.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
9.4.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
9.5.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
9.5.3. Market Opportunity Analysis
9.6. Global Bioabsorbable Vascular Scaffolds Market- Opportunity Analysis Index - By Product Type, By Material Type, By Application, By End User, and Region, 2019 – 2025
10. North America Bioabsorbable Vascular Scaffolds Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
10.1.1. Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
10.1.1.1. Synthetic
10.1.1.2. Biological
10.1.1.3. Biosynthetic
10.1.2. Material Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
10.1.2.1. Metal based BVS
10.1.2.2. Polymer based BVS
10.1.3. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
10.1.3.1. Coronary Artery Stents
10.1.3.2. Peripheral Artery Stents
10.1.4. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
10.1.4.1. Hospitals
10.1.4.2. Cardiac Centres
10.1.4.3. Ambulatory Surgical Centres
10.1.5. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn Y-o-Y Growth % and Market Share %
10.1.5.1. U.S.
10.1.5.2. Canada
10.1.6. North America Bioabsorbable Vascular Scaffolds Market- Opportunity Analysis Index - By Product Type, By Material Type, By Application, By End User, and Country, 2019 – 2025
10.1.7. North America Bioabsorbable Vascular Scaffolds Market Dynamics – Trends
11. Europe Bioabsorbable Vascular Scaffolds Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
11.1.1. Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
11.1.1.1. Synthetic
11.1.1.2. Biological
11.1.1.3. Biosynthetic
11.1.2. Material Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
11.1.2.1. Metal based BVS
11.1.2.2. Polymer based BVS
11.1.3. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
11.1.3.1. Coronary Artery Stents
11.1.3.2. Peripheral Artery Stents
11.1.4. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
11.1.4.1. Hospitals
11.1.4.2. Cardiac Centres
11.1.4.3. Ambulatory Surgical Centres
11.1.5. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
11.1.5.1. Germany
11.1.5.2. UK
11.1.5.3. France
11.1.5.4. Spain
11.1.5.5. Italy
11.1.5.6. Russia
11.1.5.7. Poland
11.1.5.8. Rest of Europe
11.1.6. Europe Bioabsorbable Vascular Scaffolds Market- Opportunity Analysis Index - By Product Type, By Material Type, By Application, By End User, and Country, 2019 – 2025
11.1.7. Europe Bioabsorbable Vascular Scaffolds Market Dynamics – Trends
12. Asia-Pacific Bioabsorbable Vascular Scaffolds Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
12.1.1. Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
12.1.1.1. Synthetic
12.1.1.2. Biological
12.1.1.3. Biosynthetic
12.1.2. Material Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
12.1.2.1. Metal based BVS
12.1.2.2. Polymer based BVS
12.1.3. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
12.1.3.1. Coronary Artery Stents
12.1.3.2. Peripheral Artery Stents
12.1.4. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
12.1.4.1. Hospitals
12.1.4.2. Cardiac Centres
12.1.4.3. Ambulatory Surgical Centres
12.1.5. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn,
Y-o-Y Growth %, and Market Share %
12.1.5.1. Japan
12.1.5.2. China
12.1.5.3. India
12.1.5.4. ASEAN
12.1.5.5. Australia & New Zealand
12.1.5.6. Rest of Asia-Pacific
12.1.6. Asia-Pacific Bioabsorbable Vascular Scaffolds Market- Opportunity Analysis Index - By Product Type, By Material Type, By Application, By End User, and Country, 2019 – 2025
12.1.7. Asia-Pacific Bioabsorbable Vascular Scaffolds Market Dynamics – Trends
13. Latin America Bioabsorbable Vascular Scaffolds Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
13.1.1. Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
13.1.1.1. Synthetic
13.1.1.2. Biological
13.1.1.3. Biosynthetic
13.1.2. Material Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
13.1.2.1. Metal based BVS
13.1.2.2. Polymer based BVS
13.1.3. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
13.1.3.1. Coronary Artery Stents
13.1.3.2. Peripheral Artery Stents
13.1.4. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
13.1.4.1. Hospitals
13.1.4.2. Cardiac Centres
13.1.4.3. Ambulatory Surgical Centres
13.1.5. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
13.1.5.1. Brazil
13.1.5.2. Mexico
13.1.5.3. Argentina
13.1.5.4. Venezuela
13.1.5.5. Rest of Latin America
13.1.6. Latin America Bioabsorbable Vascular Scaffolds Market- Opportunity Analysis Index - By Product Type, By Material Type, By Application, End User, and Country, 2019 – 2025
13.1.7. Latin America Bioabsorbable Vascular Scaffolds Market Dynamics – Trends
14. Middle East & Africa Bioabsorbable Vascular Scaffolds Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
14.1.1. Product Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
14.1.1.1. Synthetic
14.1.1.2. Biological
14.1.1.3. Biosynthetic
14.1.2. Material Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
14.1.2.1. Metal based BVS
14.1.2.2. Polymer based BVS
14.1.3. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
14.1.3.1. Coronary Artery Stents
14.1.3.2. Peripheral Artery Stents
14.1.4. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
14.1.4.1. Hospitals
14.1.4.2. Cardiac Centres
14.1.4.3. Ambulatory Surgical Centres
14.1.5. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth %, and Market Share %
14.1.5.1. Gulf Cooperation Council GCC Countries
14.1.5.2. Israel
14.1.5.3. South Africa
14.1.5.4. Rest of MEA
14.1.6. MEA Bioabsorbable Vascular Scaffolds Market- Opportunity Analysis Index - By Product Type, By Material Type, By Application, By End User, and Country, 2019 – 2025
14.1.7. MEA Bioabsorbable Vascular Scaffolds Market Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis
15.2.1. Medtronic U.S.
15.2.2. Abbott Laboratories U.S
15.2.3. Boston Scientific Corporation U.S.
15.2.4. Biosensors International Group, Ltd. Singapore
15.2.5. Biotronik SE & Co. KG Germany
15.2.6. C.R. Bard Inc. U.S.
15.2.7. Stentys SA France
15.2.8. Svelte Medical Systems, Inc. U.S.
15.2.9. REVA Medical, Inc. U.S.
16. Research Methodology
17. Key Assumptions and Acronyms


Please fill the following form to know more details about this Report




RELATED PRODUCTS



CHOOSE A FORMAT


  •  Single User Price : $ 4400
  •  Enterprise User License : $ 6600
  •  Corporate User License : $ 8900

Have A Question ?


  DOWNLOAD SAMPLE



TESTIMONIALS

I am completely satisfied with the information given in the sample pages of the report and I am waiting for the affirmative response from my peers and colleagues to purchase it.hey answered to all my queries promptly. I am highly satisfied!!
John Keats
We received a very quick response to all our queries on the RTLS report and we were also given a free consult with analyst for 15 minutes. It is refreshing (and increasingly rare) to have a new company go the extra mile to win the confidence of the customer
Ernest Hemingway
I would like to express my gratitude for the excellent service received this morning from the support team. They acknowledged my concern of adding me to the secondary user's list immediately. Thank you for this excellent, speedy and thoughtful service
Jacob Watson

CUSTOM RESEARCH

Still haven't found what you're looking for ?
Speak to our Custom Research Team